Effects on rat brain κ1- and κ2-opioid receptors after chronic treatment with non-peptide κ-agonists

Journal of Pharmacy and Pharmacology

Volumn 50, Issue 10, 1998, Pages 1121-1125

  Mcconnaughey, Mona M ^a   Zhai, Qing Zhu ^b   Ingenito, Alphonse J ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; BREMAZOCINE; DYNORPHIN; KAPPA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR AGONIST; RECEPTOR SUBTYPE; SPIRADOLINE MESILATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIHYPERTENSIVE THERAPY; ARTICLE; BINDING SITE; BLOOD PRESSURE; BRAIN; BRAIN CORTEX; CONTROLLED STUDY; HIPPOCAMPUS; HYPOTHALAMUS; LONG TERM CARE; MALE; MESENCEPHALON; NONHUMAN; OSMOTIC MINIPUMP; PONS; RAT; RECEPTOR AFFINITY; RECEPTOR BINDING; RECEPTOR DENSITY; SPONTANEOUSLY HYPERTENSIVE RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0031737524     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-7158.1998.tb03322.x     Document Type: Article

References (27)

1. Bhargava, H. N., Gulati, A., Ramarao, P. (1989a) Effect of chronic administration of U-50-488H on tolerance to its pharmacological actions and on multiple opioid receptors in rat brain regions and spinal cord. J. Pharmacol. Exp. Ther. 251: 21-26
2. Bhargava, H. N., Ramarao, P., Gulati, A. (1989b) Effects of morphine in rats treated chronically with U-50,488 H, a κ-opioid receptor agonist. Eur. J. Pharmacol. 162: 257-264
3. Chang, K. J., Eckel, R. W., Blanchard, S. G. (1982) Opioid peptides induce reduction of enkephalin receptors in cultured neuroblastoma cell. Nature 296: 446-448
4. Cox, B. (1990) Drug tolerance and physical dependence. In: Pratt, W. B., Taylor, P. (eds) Principals of Drug Action. 3rd edn, Churchill Livingston, NY, pp 689-690
5. Fujibayashi, K., Sakamoto, K., Watanabe, K., Iizuka, Y. (1994) Pharmacological properties of R-84760, a novel k-opioid receptor agonist. Eur. J. Pharmacol. 261: 133-140
6. Gulati, A., Bhargava, H. N. (1988) Cardiovascular responses to kappa opioid agonists in intact and adrenal demedulated rats. Eur. J. Pharmacol. 156: 247-257
7. Hassen, A. H., Feuerstein, G., Faden, A. I. (1984) Kappa opioid receptors modulate cardiorespiratory function in hind-brain nuclei of rat. J. Neurosci. 4: 2213-2200
8. Holiday, J. W., Tortella, F. C., Meyerhoff, J. L., Belenky, G. L., Hitzemann, R. J. (1986) Electroconvulsive shock activates endogenous opioid systems: behavioral and biochemical correlates. Ann. NY Acad. Sci. 467: 249-255
9. Kunos, G., Farsang, C., Ramirez-Gonzales, M. D. (1981) Beta-endorphin: possible involvement in the antihypertensive effect of central alpha-receptor activation. Science 211: 82-84
10. Li, S. J., Wong, S. C., Ingenito, A. J. (1989) A low hippocampal dynorphin A(1-8) immunoreactivity in spontaneously hypertensive rats. Neuropeptides 13: 197-200
11. Li, S. J., Hong, J. S., Ingenito, A. J. (1990) Hippocampal levels of dynorphin A(1-8) in neonatal and 16-week-old spontaneously hypertensive rats: comparisons with DOCA-salt hypertension. Neurochem. Res. 11: 1141-1146
12. Li, S. J., Wong, S. C., Hong, J. S., Ingenito, A. J. (1992) Age-related changes in opioid peptide concentrations in brain and pituitary of spontaneously hypertensive rats. Pharmacology 44: 245-256
13. Lowry, O. H., Rosebrough, N. J., Fair, A. L., Randall, R. J. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275
14. Mastrianni, J. A., Ingenito, A. J. (1987) On the relationship between clonidine hypotension and brain beta-endorphin in the spontaneously hypertensive rat: studies with alpha adrenergic and opiate blockers. J. Pharmacol. Exp. Ther. 242: 378-387
15. Morris, B. J., Herz, A. (1989) Control of opiate receptor number in vivo: simultaneous κ-receptor down-regulation and μ-receptor up-regulation following chronic agonist/ antagonist treatment. Neuroscience 29: 433-442
16. Numata, H., Hiranuma, T., Oka, T. (1988) Inactivation of dynorphin-1-8 in isolated preparations by three peptidases. Jpn J. Pharmacol. 47: 417-423
17. Pasternak, G. W. (1993) Pharmacological mechanisms of opioid analgesics. Clin. Neuropharmacol. 16: 1-18
18. Privette, T. H., Wang, J. Q., Ingenito, A. J., Terrian, D. M. (1994) Dentate granule cells as a central cardioregulatory site in the rat. Brain Res. 656: 295-301
19. Raynor, K., Kong, H., Hines, J., Kong, G., Benovic, J., Yasuda, K., Bell, G. I., Reisine, T. (1994) Molecular mechanisms of agonist-induced desensitization of the cloned mouse kappa opioid receptor. J. Pharmacol. Exp. Ther. 270: 1381-1386
20. Scatchard, G. (1949) The attraction of proteins for small molecules and ions. Ann. NY Acad. Sci. 51: 660
21. Vonvoightlander, P. F., Lewis, R. A. (1988) Analgesic and mechanistic evaluation of spiradoline, a potent kappa agonist. J. Pharmacol. Exp. Ther. 246: 259-262
22. Vonvoightlander, P. F., Lahti, R. A., Ludens, J. H. (1983) U-50,488H: a selective and structurally novel-non-mu (kappa) opioid agonist. J. Pharmacol. Exp. Ther. 224: 7-12
23. Wang, J. Q., Ingenito, A. J. (1992) Centrally mediated cardiovascular actions of dynorphin A(1-8) on rat hippocampal formation. J. Pharmacol. Exp. Ther. 261: 678-685
24. Wang, J. Q., Ingenito, A. J. (1994) Comparative effects of intra hippocampal injection of dynorphin A(1-8), (1-13), (1-17), U-50,488H and dynorphin B on blood pressure and heart rate in spontaneously hypertensive and normotensive Wistar Kyoto rats. Peptides 15: 125-132
25. Yoburn, B. C., Shah, S., Chan, K., Duttaroy, A., Davis, T. (1995) Supersensitivity to opioid analgesics following chronic opioid antagonist treatment: relationship to receptor selectivity. Pharmacol. Biochem. Behav. 51: 535-539
26. Zhai, Q. Z., Ingenito, A. J. (1997) Sustained antihypertensive effects of chronic administration of two κ-opioid agonists in spontaneously hypertensive rats. Am. J. Ther. 4: 173-180
27. Zukin, R. S., Pellegrini-Giampietro, D. E., Knapp, C. M., Tempel, A. (1993) Opioid receptor regulation. In: Born, G. V. R. (ed.) Handbook of Experimental Pharmacology, vol. 104, Springer, NY, pp 107-123